Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOsirium Tech Regulatory News (OSI)

  • This share is currently suspended. It was suspended at a price of 2.20
  • There is currently no data for OSI

Trading Update

8 Jul 2022 07:00

RNS Number : 7532R
Osirium Technologies PLC
08 July 2022
 

The information contained within this announcement is deemed by the Company to constitute inside information pursuant to Article 7 of EU Regulation 596/2014 as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 as amended.

 

8 July 2022

 

Osirium Technologies plc

("Osirium" or the "Group")

 

Trading Update

 

Record half year performance for bookings and revenue

 

Osirium Technologies plc (AIM: OSI), a leading vendor of cloud-based cybersecurity and IT automation software, announces an update on trading for the six months ended 30 June 2022.

 

The positive trading momentum reported in the Company's Q1 2022 trading update has continued through Q2, and the Board expects to report the Group's best six-month figures for bookings and revenue:

 

·

Bookings increase of 30% to not less than £1.18 million (1H 2021: £0.91 million), with more than 50% of the value coming from new customer wins

·

Revenue of £0.91 million (1H 2021: £0.74 million)

·

Deferred revenue increased 14% to £1.91 million (1H 2021: £1.68 million), providing enhanced visibility

·

Debtors and cash balances as at 30 June 2022 were £0.61 million

 

The Board recognises that annualised recurring revenue ("ARR") is a key industry measurement of the size of a SaaS Company's subscription revenues and has decided to adopt this as a key performance indicator going forward. For June 2022, the Group's ARR* was £1.61 million, an increase of 11% since the start of the year (December 2021: £1.45 million) and 29% over the past 12 months (June 2021: £1.25 million).

 

The Group is pleased to report a continuing increase in average contract size amongst its new customer acquisitions. New contracts have been signed across a range of sectors during the period, including notable wins in healthcare, higher education and financial services. The Group expects these markets to continue to be key growth drivers in H2 and beyond.

 

In line with its land-and-expand strategy, Osirium has also expanded licenses with existing customers, including with a number of the Group's NHS customers signed in 2021.

 

Aided by its international channel partner network of resellers and distributors, the Group has signed deals in two new geographies, the USA and Finland, during H1.

 

The Group has seen the continued strong growth of its newer products. Increasing numbers of PAM customers are adding PPA and PEM to their environments and the Group also announced its first deals where these products were the main component during H1. The growth in demand for these products provides the important opportunity for cross-selling and up-selling.

 

Reflecting this cross-selling opportunity, Osirium is pleased to announce it has signed a contract expansion with an existing customer, a major UK provider of telephony and broadband services. Initially signed as a 36-month PAM deal in December 2020, this customer has now expanded its scope to include Osirium's PPA and PEM solutions. This sale, won in conjunction with Osirium's channel partner Nomios, is the first where all three Osirium privileged security products will be utilised.

 

With a good pipeline of opportunity ahead, an enhanced base of deferred revenue and an ongoing trend towards privileged security procurement, the Board remains confident of meeting revenue and bookings guidance for the full year. The Board maintains a focus on balancing investment alongside managing costs and will continue to ensure the appropriate structures are in place to support the growth strategy. As announced at the time of the Group's fundraising in February 2022, the Group will be required to raise additional capital in the second half of 2022 and the Board continues to assess all available options in this regard.

 

The Group expects to report its interim results for the period in September 2022.

 

* ARR is calculated by annualising revenue recognised in a given month from all clients on deployed subscription contracts

 

David Guyatt, Chief Executive Officer of Osirium said:

 

"Our record half for bookings and revenue shows the continued drive in the business as we increase our customer base as well as average total contract values. This is facilitated through the expansion of our products and additional licenses and our well-established channel partner network which extends into new territories underserved by our competitors.

 

"There remains an opportunity to scale the business significantly and I am pleased with the progress made in the first half of the year."

 

Contacts:

Osirium Technologies plc

Tel: +44 (0)1183 242 444

David Guyatt, CEO

Rupert Hutton, CFO

Allenby Capital Limited (Nominated adviser and broker)

Tel: +44 (0)20 3328 5656

James Reeve / George Payne (Corporate Finance)

Tony Quirke (Sales and Corporate Broking)

Alma PR (Financial PR adviser)

Tel: +44 (0)20 3405 0205

Hilary Buchanan

osirium@almapr.co.uk

Kieran Breheny

William Ellis Hancock

 

 

About Osirium Technologies Plc

 

Osirium Technologies plc (AIM: OSI) is a leading UK-based cybersecurity software vendor delivering Privileged Access Management (PAM), Privileged Endpoint Management (PEM) and Osirium Automation solutions that are uniquely simple to deploy and maintain. 

 

With privileged credentials involved in over 80% of security breaches, customers rely on Osirium PAM's innovative technology to secure their critical infrastructure by controlling 3rd party access, protecting against insider threats, and demonstrating rigorous compliance. Osirium Automation delivers time and cost savings by automating complex, multi-system processes securely, allowing them to be delegated to Help Desk engineers or end-users and to free up specialist IT resources. The Osirium PEM solution balances security and productivity by removing risky local administrator rights from users, while at the same time allowing escalated privileges for specific applications.

 

Founded in 2008 and with its headquarters in Reading, UK, the Group was admitted to trading on AIM in April 2016. For further information please visit www.osirium.com.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTFLFEEDVIDIIF
Date   Source Headline
16th Mar 20225:50 pmRNSHolding(s) in Company
14th Mar 20224:40 pmRNSSecond Price Monitoring Extn
14th Mar 20224:35 pmRNSPrice Monitoring Extension
11th Mar 20229:05 amRNSSecond Price Monitoring Extn
11th Mar 20229:00 amRNSPrice Monitoring Extension
10th Mar 20222:16 pmRNSHolding(s) in Company
10th Mar 202211:06 amRNSSecond Price Monitoring Extn
10th Mar 202211:00 amRNSPrice Monitoring Extension
10th Mar 202210:50 amRNSHolding(s) in Company
7th Mar 20224:44 pmRNSHolding(s) in Company
7th Mar 202212:15 pmRNSResult of General Meeting
2nd Mar 20227:00 amRNSNew Customer Wins
1st Mar 20225:00 pmRNSHolding(s) in Company
28th Feb 20225:00 pmRNSTotal Voting Rights
18th Feb 20222:52 pmRNSHolding(s) in Company
11th Feb 20222:06 pmRNSSecond Price Monitoring Extn
11th Feb 20222:00 pmRNSPrice Monitoring Extension
11th Feb 202210:30 amRNSProposed Placing and Subscription and Notice of GM
14th Jan 20227:01 amRNSTrading Update
14th Jan 20227:00 amRNSChange of Adviser
29th Nov 20217:00 amRNSTrading Update
8th Nov 20217:00 amRNSChannel Partner and Marketing Update
28th Sep 20217:00 amRNSInterim Results
8th Sep 20217:00 amRNSRelease of findings from Osirium Ransomware Index
20th Aug 20217:00 amRNSChange of Auditor
22nd Jul 20212:30 pmRNSResult of AGM
11th Jun 20217:00 amRNSFinal Results
1st Jun 20217:00 amRNSTotal Voting Rights
21st May 20214:00 pmRNSHolding(s) in Company
20th May 20219:05 amRNSHolding(s) in Company
19th May 20214:24 pmRNSHolding(s) in Company
12th May 20215:16 pmRNSResults of General Meeting
4th May 20217:00 amRNSTotal Voting Rights
30th Apr 202112:43 pmRNSHolding(s) in Company
29th Apr 20216:30 pmRNSHolding(s) in Company
29th Apr 20216:29 pmRNSHolding(s) in Company
27th Apr 20217:00 amRNSPublication of Circular & Notice of GM
23rd Apr 20217:00 amRNSResult of Placing and Subscription & TVR
22nd Apr 20214:41 pmRNSProposed Placing and Subscription & Notice of GM
11th Mar 20217:00 amRNSNHS Trust Customer Wins
1st Feb 20217:00 amRNSNew Patent Granted
15th Jan 20217:00 amRNSTrading Update
9th Dec 20207:00 amRNSContract win with additional UK Ambulance Service
4th Dec 20207:00 amRNSGrant of Options
2nd Dec 202011:05 amRNSSecond Price Monitoring Extn
2nd Dec 202011:01 amRNSPrice Monitoring Extension
2nd Dec 20209:05 amRNSSecond Price Monitoring Extn
2nd Dec 20209:00 amRNSPrice Monitoring Extension
2nd Dec 20207:00 amRNSContract win with major UK communications provider
10th Nov 20204:35 pmRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.